Editorial
Biomarkers in malignant mesothelioma—an unfulfilled need or a waste of resources?
Abstract
The search for a molecular biomarker in malignant mesothelioma is as old as its first proven effective therapy (1,2). A definitive diagnostic biomarker could aid in establishing the diagnosis of malignant mesothelioma in patient.